Citius Oncology, Inc. CTOR Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s other non-current assets?
- Citius Oncology, Inc. (CTOR) reported other non-current assets of $71.28M in Q1 2026.
- How has Citius Oncology, Inc.'s other non-current assets changed year-over-year?
- Citius Oncology, Inc.'s other non-current assets decreased by 2.9% year-over-year, from $73.4M to $71.28M.
- What is the long-term trend for Citius Oncology, Inc.'s other non-current assets?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s other non-current assets has grown at a 35.5% compound annual growth rate (CAGR), from $40M to $73.4M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.